We report a de novo 12q22-q23.3 duplication detected by whole-genome array comparative genomic hybridization (array-CGH) in a 5-year-old girl with temporal lobe epilepsy and intellectual disability. The 12Mb duplication encompasses 67 genes, many of which have an established function in brain development and functioning. In particular, it includes DEPDC4, a gene belonging to the IML1 family of proteins involved in G-protein signaling pathways, regulating cells growth and development which also include DEPDC5, which is mutated in autosomal dominant focal epilepsy with variable foci and in few families with familial TLE.
Introduction
Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy and may be associated with acquired central nervous system lesions (symptomatic cases) or be genetic in the origin.
Family studies have shown that relatives of patients with temporal lobe epilepsy are at higher risk of suffering from seizures and EEG abnormalities compared to relatives of controls. Therefore, various susceptibility genes and environmental factors are believed to be involved in the aetiology of TLE, which is considered to be a heterogeneous, polygenic, and complex disorder. Rare point mutations in LGI1, DEPDC5 and RELN have been reported in families with a monogenic type of TLE and only a few anaedoctical copy number variations (CNVs) have been described in TLE [1, 2] .
We report a partial duplication of the long arm of chromosome 12 detected by whole-genome array comparative genomic hybridization in a 5-years old girl with temporal lobe epilepsy.
Case study
This girl was the second child of Caucasian healthy nonconsanguineous parents. Familial history was unremarkable. The girl was born at 37 weeks + 5 days gestation by a cesarean section. Perinatal and neonatal periods were uneventfully. At birth, she weighted 3460 g (75-90th centile), length was 51 cm (90th centile), and occipitofrontal circumference (OFC) was 34,5 cm (75-90th centile). The girl's development milestones were mildly delayed: she acquired head control at 4 months, sitting position at 10 months, and she started walking at 17 months. She pronounced her first words at age of 2 years and 5 months. At 30 months, the patient experienced a simple tonic-clonic seizure during fever.
At 3 years and 3 months of life, she was admitted to our department due to a second febrile seizure, characterised by loss of contact, oromasticatory automatisms, and left head deviation, lasting about 5 min with post-ictal somnolence. In the following D U P L I C A T E months, the girls suffered from weekly dyscognitive seizures with impaired contact and oromasticatory or gestural automatisms, lasting up to a few minutes.
At observation, she presented macrosomy [weight 22,7 kg (>97th centile), height 104 cm (>97th centile), OFC 51 cm (50th centile)]; examination revealed mild dysmorphic features: straight eyebrows, sinophris, abnormal internal canthal folds, large nasal philtrum, small mouth, bilateral shortness of the fifth finger, bilateral syndactyly of the second and third toes and revolved fifth toenails (Fig. 1A) . Biochemical investigations (i.e. glycemia, hepatorenal function, inflammatory markers, ionogram, ammonia, coagulation values, complete blood cells count) were normal. Griffiths Scale of Mental Development assessed her global developmental quotient (DQ) at 78 with predominantly language impairment (she pronounces about 10 words).
Inter-ictal EEG revealed high voltage paroxysmal anomalies in the posterior region of the right temporal area, more evident during sleep recordation (Fig. 1B) Fig. 2A) .
Discussion
This is the first reported case of de novo 12q22-q23.3 duplication associated with temporal lobe epilepsy.
We identified a patient with an overlapping de novo duplication which was already described in the DECIPHER v8.9 database (ID 258582) (Fig. 2B) . Both Decipher's patient and our case share dysmorphic features, focal epilepsy, and intellectual disability; in addition, patient 258582 also featured obesity, myopia, and strabismus.
In our case, the 12Mb duplication at 12q22-q23.3 encompasses 67 genes, many of which have an established function in brain development and functioning (Fig. 2C) .
In 2004 a locus for TLE was mapped in this region by linkage analysis performed on a large family segregating idiopathic temporal lobe epilepsy and febrile seizures in 21 members. The reported phenotype was characterised by temporal lobe epilepsy with average age of onset at eight years, recurrence of febrile seizures in about half of the individuals, no hippocampal sclerosis, and a usually good prognosis [3] . Additional evidence for an epilepsy at this locus was provided by a second, large Caucasian family study showing febrile and afebrile focal seizures [4] .
Comparative analysis of the locus identified by Claes et al. and duplicated regions in our case and in patient 258582 shows an overlapping genomic segment of about 6.1 Mb. This region includes 27 genes and, among these, DEPDC4 represents an appealing candidate for a causative role. Indeed, DEPDC4 gene belongs to the IML1 family of proteins involved in G-protein signaling pathways, regulating cells growth and development which also include DEPDC5. Mutations in this gene have been identified in autosomal dominant focal epilepsy with variable foci and in few families with familial TLE [2] .
Conclusion
Our study confirms the presence of a candidate locus for autosomal dominant familial temporal lobe epilepsy (TLE) with febrile seizures on chromosome 12q22-q23.3 and highlights the important role of CNVs in the genetic aetiology of epilepsy. 
